| Literature DB >> 32268117 |
Katerina Rohlenova1, Jermaine Goveia1, Melissa García-Caballero1, Abhishek Subramanian1, Joanna Kalucka1, Lucas Treps1, Kim D Falkenberg1, Laura P M H de Rooij1, Yingfeng Zheng2, Lin Lin3, Liliana Sokol1, Laure-Anne Teuwen4, Vincent Geldhof1, Federico Taverna1, Andreas Pircher1, Lena-Christin Conradi1, Shawez Khan1, Steve Stegen5, Dena Panovska6, Frederik De Smet6, Frank J T Staal7, Rene J Mclaughlin7, Stefan Vinckier1, Tine Van Bergen8, Nadine Ectors6, Patrik De Haes8, Jian Wang9, Lars Bolund3, Luc Schoonjans10, Tobias K Karakach1, Huanming Yang9, Geert Carmeliet5, Yizhi Liu2, Bernard Thienpont11, Mieke Dewerchin1, Guy Eelen1, Xuri Li12, Yonglun Luo13, Peter Carmeliet14.
Abstract
Endothelial cell (EC) metabolism is an emerging target for anti-angiogenic therapy in tumor angiogenesis and choroidal neovascularization (CNV), but little is known about individual EC metabolic transcriptomes. By single-cell RNA sequencing 28,337 murine choroidal ECs (CECs) and sprouting CNV-ECs, we constructed a taxonomy to characterize their heterogeneity. Comparison with murine lung tumor ECs (TECs) revealed congruent marker gene expression by distinct EC phenotypes across tissues and diseases, suggesting similar angiogenic mechanisms. Trajectory inference predicted that differentiation of venous to angiogenic ECs was accompanied by metabolic transcriptome plasticity. ECs displayed metabolic transcriptome heterogeneity during cell-cycle progression and in quiescence. Hypothesizing that conserved genes are important, we used an integrated analysis, based on congruent transcriptome analysis, CEC-tailored genome-scale metabolic modeling, and gene expression meta-analysis in cross-species datasets, followed by in vitro and in vivo validation, to identify SQLE and ALDH18A1 as previously unknown metabolic angiogenic targets.Entities:
Keywords: angiogenesis; choroidal neovascularization; endothelial cells; metabolism; scRNA-seq; tumor angiogenesis
Year: 2020 PMID: 32268117 DOI: 10.1016/j.cmet.2020.03.009
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287